In Vivo Electroporation-Mediated, Intrahepatic Alpha1 Antitrypsin Gene Transfer Reduces Pulmonary Emphysema in Pallid Mice
Authors:
Open Access
- 21 August 2020
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (9) , 793
Abstract
Rationale: Mutation in the alpha1 antitrypsin (AAT) gene leads to low circulating levels of AAT, which is associated with several disease processes including pulmonary emphysema. The standard of care relies on substitution with plasma-purified AAT. We studied a novel approach to obtain sustained therapeutic levels of circulating AAT using nonviral in vivo electroporation-mediated gene transfer to the liver. Methods: In vivo intrahepatic electroporation-mediated human AAT gene transfer was performed in C57 Bl/6J mice carrying a genetic deficiency of murine AAT (pallid mice) and suffering from pulmonary emphysema. The animals were evaluated for lung function using flexiVent and detailed stereological assessments. Lung neutrophilic burden was assessed. Results: Pallid mice showed morphologically detectable pulmonary emphysema. Thirty days after in vivo electroporation-mediated gene transfer directly aimed at the liver, circulating human AAT was elevated and lung function was significantly improved compared to non-treated pallid mice. Stereological analysis revealed a reduction in pulmonary emphysema. Conclusion: Our data indicate that in vivo intrahepatic electroporation-mediated gene transfer of AAT is a safe and efficient procedure resulting in reduction of pulmonary emphysema in pallid mice.Keywords
Funding Information
- Lungenliga Schweiz (2014-13)
- OPO-Stiftung (2014)
This publication has 38 references indexed in Scilit:
- Update on α1-antitrypsin deficiencyBreathe, 2018
- Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung DiseaseAnnals of the American Thoracic Society, 2016
- Current and Emerging Treatments for Alpha-1 Antitrypsin Deficiency.2016
- Outdoor air pollution is associated with rapid decline of lung function in α-1-antitrypsin deficiencyOccupational and Environmental Medicine, 2010
- In vivo electroporation and ubiquitin promoter – a protocol for sustained gene expression in the lungThe Journal of Gene Medicine, 2006
- Electroporation-Enhanced Nonviral Gene Transfer for the Prevention or Treatment of Immunological, Endocrine and Neoplastic DiseasesCurrent Gene Therapy, 2006
- Electroporation‐mediated interleukin‐10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allograftsThe Journal of Gene Medicine, 2006
- 1-Antitrypsin deficiency * 4: Molecular pathophysiologyThorax, 2004
- Worldwide Racial and Ethnic Distribution of α1-Antitrypsin DeficiencyChest, 2002
- Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease.American Journal of Public Health, 1991